「行動嗜癖」の版間の差分

ナビゲーションに移動 検索に移動

行動嗜癖 (ソースを閲覧)

2014年1月8日 (水) 17:23時点における版

7,377 バイト除去 、 2014年1月8日 (水)
細
編集の要約なし
細編集の要約なし
細編集の要約なし
74行目: 74行目:
== 併存精神障害 ==
== 併存精神障害 ==


　嗜癖や依存をもつ者は、他にも様々な精神障害を併存することが多いといわれる<ref name=ref25><pubmed>18257941</pubmed></ref> <ref name=ref26><pubmed>15889941</pubmed></ref> <ref name=ref27><pubmed>18052565</pubmed></ref> <ref name=ref28>'''Black DW'''<br>Epidemiology and phenomenology of compulsive buying disorder. <br>In: (eds.) Gtant, J. and Potenza, M. Oxford Handbook of Impulse Control Disorders, <br>''Oxford University Press'', New York, 2011, 196-208</ref> <ref name=ref29><pubmed>8063088</pubmed></ref> <ref name=ref30>田中克俊（分担研究者）<br>いわゆるギャンブル依存症の実態と地域ケアの促進<br>
　嗜癖や依存をもつ者は、他にも様々な精神障害を併存することが多いといわれる<ref name=ref25><pubmed>18257941</pubmed></ref> <ref name=ref26><pubmed>15889941</pubmed></ref> <ref name=ref27><pubmed>18052565</pubmed></ref> <ref name=ref28>'''Black DW'''<br>Epidemiology and phenomenology of compulsive buying disorder. <br>In: (eds.) Gtant, J. and Potenza, M. Oxford Handbook of Impulse Control Disorders, <br>''Oxford University Press'', New York, 2011, 196-208</ref> <ref name=ref29><pubmed>8063088</pubmed></ref> <ref name=ref30>'''田中克俊'''（分担研究者）<br>いわゆるギャンブル依存症の実態と地域ケアの促進<br>
厚生労働科学研究費補助金（障害保健福祉総合研究事業）平成19～21年度総合分担研究報告書: 2010.</ref>。
厚生労働科学研究費補助金（障害保健福祉総合研究事業）平成19～21年度総合分担研究報告書: 2010.</ref>。


108行目: 108行目:
== 参考文献 ==
== 参考文献 ==
<references />
<references />
1. Holden C.
'Behavioral' addictions: do they exist?
Science: 2001, 294(5544);980-982.
2. 洲脇寛
嗜癖行動障害の臨床概念をめぐって.
精神神経学雑誌: 2004, 106(10);1307-1313
3. Probst CC, van Eimeren T
The Functional Anatomy of Impulse Control Disorders.
Curr Neurol Neurosci Rep: 2013, 13(10);386-395.
4. Heatherton TF, Wagner DD
Cognitive neuroscience of self-regulation failure.
Trends Cogn Sci: 2011, 15(3);132-139.
5. Goldstein RZ, Volkow ND
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.
Am J Psychiatry: 2002, 159(10);1642-1652
6. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich [[GR]], Lang AE
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Arch Neurol: 2010, 67(5);589-595
7. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
Brain: 2009, 132(Pt 5);1376-85
8. Goldstein RZ, Volkow ND
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.
Nat Rev Neurosci:  2011, 12(11);652-669.
9. Everitt BJ, Robbins TW
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.
Nat Neurosci: 2005, 8(11);1481-1489.
10. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C
Pathological gambling is linked to reduced activation of the mesolimbic reward system.
Nat Neurosci: 2005, 8(2);147-148.
11. Brewer JA, Potenza MN
The neurobiology and genetics of impulse control disorders: relationships to drug addictions.
Biochem Pharmacol: 2008, 75(1);63-75.
12. Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC
Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions.
J Neurosci: 2012, 32(41);14094-101.
13. Smith KS, Berridge KC
Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum.
J Neurosci: 2007, 27(7);1594-1605.
14. Tyacke RJ, Lingford-Hughes A, Reed LJ, Nutt DJ
GABAB receptors in addiction and its treatment.
Adv Pharmacol: 2010, 58;373-396.
15. Hicks CW, Pandya MM, Itin I, Fernandez HH
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.
Parkinsonism Relat Disord; 2011, 17(5);379-381
16. Kelley AE, Berridge KC
The neuroscience of natural rewards: relevance to addictive drugs.
J Neurosci: 2002, 22(9);3306-3311.
17. Kalivas PW, Volkow N, Seamans J
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission.
Neuron: 2005, 45(5);647-650.
18. Dannon PN, Rosenberg O, Schoenfeld N, Kotler M
Acamprosate and Baclofen were Not Effective in the Treatment of Pathological Gambling: Preliminary Blind Rater Comparison Study.
Front Psychiatry: 2011, 2;33.
19. Olive MF, Cleva RM, Kalivas PW, Malcolm RJ
Glutamatergic medications for the treatment of drug and behavioral addictions.
Pharmacol Biochem Behav: 2012 , 100(4);801-810
20. Cools R, Nakamura K, Daw ND
Serotonin and dopamine: unifying affective, activational, and decision functions.
Neuropsychopharmacology: 2011, 36(1);98-113.
21. Blum K, Chen AL, Chen TJ, Braverman [[ER]], Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Theor Biol Med Model: 2008, 12;5;24
22. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, Cook S, Broft A, Van Heertum R, Comer SD
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.
Biol Psychiatry: 2012, 1;71(3);192-198
23. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.
Nature: 1997, 24;386(6627);830-833.
24. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
Am J Psychiatry: 2001, 158(12);2015-2021.
25. Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ
DSM-IV pathological gambling in the National Comorbidity Survey Replication.
Psychol Med: 2008, 38(9);1351-1360.
26. Petry NM, Stinson FS, Grant BF
Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
J Clin Psychiatry: 2005, 66(5);564-574.
27. Grant JE, Won Kim S
Clinical characteristics and psychiatric comorbidity of pyromania.
J Clin Psychiatry: 2007, 68(11);1717-1722.
28. Black DW
Epidemiology and phenomenology of compulsive buying disorder. In
: (eds.) Gtant, J. and Potenza, M. Oxford Handbook of Impulse Control Disorders, Oxford University Press, New York, 2011, 196-208
29. Schlosser S, Black DW, Repertinger S, Freet D
Compulsive buying. Demography, phenomenology, and comorbidity in 46 subjects.
Gen Hosp Psychiatry: 1994, 16(3);205-12.
30. 田中克俊（分担研究者）
いわゆるギャンブル依存症の実態と地域ケアの促進.
厚生労働科学研究費補助金（障害保健福祉総合研究事業）平成19～21年度総合分担研究報告書: 2010.
31. Rosenberg O, Dinur LK, Dannon PN
Four-year follow-up study of pharmacological treatment in pathological gamblers.　（naltrexoneが有効）
Clin Neuropharmacol: 2013, 36(2);42-45
32. Bosco D, Plastino M, Colica C, Bosco F, Arianna S, Vecchio A, Galati F, Cristiano D, Consoli A, Consoli D
Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
Clin Neuropharmacol: 2012, 35(3);118-120
33. Lahti T, Halme JT, Pankakoski M, Sinclair D, Alho H
Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study.
Psychopharmacol Bull: 2010, 43(3);35-44.
34. Grant JE, Kim SW, Hartman BK
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
J Clin Psychiatry: 2008, 69(5);783-789.
35. Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.
Br J Psychiatry: 2010, 197(4);330-1.
36. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Am J Psychiatry: 2006, 163(2);303-12.
37. J Horley, D Bowlby
Theory, research, and intervention with arsonists
Aggression and Violent Behavior: 2011, 16(3);241–249
38. Blaszcsynski, A
Overcoming Compulsive Gambling.
Robinson Pub, London, 2010
39. 田辺等
ギャンブル依存症（病的ギャンブリング）と自殺.
精神科治療学: 2010, 25;223-229
「https://bsd.neuroinf.jp/wiki/特別:携帯機器差分/24412」から取得

案内メニュー